Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., is medical director of Transfusion Medicine and Stem Cell Therapy at Mayo Clinic in Florida.

Using deep brain stimulation techniques, neuroscientists at Mayo Clinic are looking for early signals in the brain to help stop seizures. In their biomarker discovery initiative, a team of researchers is assessing how different stimulation patterns affect different parts of the brain. The goal, says Jonathon Parker, M.D., Ph.D., a Mayo Clinic neurosurgeon, is to personalize therapeutic brain stimulation settings for individual patients with epilepsy and other neurological disorders.

A new AI system called OncoGAN, developed by Ontario Institute for Cancer Researh (OICR) and University of Toronto researchers, creates simulated cancer genomes could reshape the tools used to analyze tumours, helping bring about more accurate cancer diagnosis and ultimately more effective treatments.